133 related articles for article (PubMed ID: 24919375)
1. [Controlled drug consumption rooms].
Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
[No Abstract] [Full Text] [Related]
2. Harm reduction drug policy.
Voth EA
Lancet Infect Dis; 2008 Sep; 8(9):528; author reply 528-9. PubMed ID: 18718436
[No Abstract] [Full Text] [Related]
3. [Cannabis and drug consumption rooms, a French impasse].
Nau JY
Rev Med Suisse; 2012 Oct; 8(360):2098-9. PubMed ID: 23185933
[No Abstract] [Full Text] [Related]
4. Supervised consumption rooms: the French Paradox.
Jauffret-Roustide M; Pedrono G; Beltzer N
Int J Drug Policy; 2013 Nov; 24(6):628-30. PubMed ID: 23777651
[No Abstract] [Full Text] [Related]
5. Drug consumption rooms: an overdue extension to harm reduction policy in the UK?
Lloyd C; Hunt N
Int J Drug Policy; 2007 Jan; 18(1):5-9. PubMed ID: 17689338
[TBL] [Abstract][Full Text] [Related]
6. NICE endorses use of needle exchange scheme to minimise infection risk.
Cole A
BMJ; 2009 Feb; 338():b771. PubMed ID: 19237409
[No Abstract] [Full Text] [Related]
7. Drug use settings: an emerging focus for research and intervention.
Kerr T; Kimber J; Rhodes T
Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
[No Abstract] [Full Text] [Related]
8. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
Jozaghi E
Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
[No Abstract] [Full Text] [Related]
9. Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.
Thakarar K; Nenninger K; Agmas W
Infect Dis Clin North Am; 2020 Sep; 34(3):605-620. PubMed ID: 32782104
[TBL] [Abstract][Full Text] [Related]
10. New hope for unsanctioned safe injection site.
Glauser W
CMAJ; 2018 Jan; 190(3):E90-E91. PubMed ID: 29358208
[No Abstract] [Full Text] [Related]
11. [The initial experience in supervised injecting facilities in Denmark].
Axelsson A; Hvam F; Bonde M; Olsen ML; Kiørboe E; Hoff-Lund O; Abildgaard M; Iversen K
Ugeskr Laeger; 2012 Sep; 174(39):2286-9. PubMed ID: 23006221
[TBL] [Abstract][Full Text] [Related]
12. Ireland is to install supervised injecting rooms.
Houston M
BMJ; 2016 Jan; 532():i406. PubMed ID: 26801053
[No Abstract] [Full Text] [Related]
13. [Harm reduction policy related to drug use: the needles exchange programs].
Emmanuelli J
Med Sci (Paris); 2004 May; 20(5):599-603. PubMed ID: 15190482
[TBL] [Abstract][Full Text] [Related]
14. Expanded access to SEPs and other harm reduction measures in France.
Carrieri MP; Desenclos JC
Addiction; 2009 Sep; 104(9):1447-8. PubMed ID: 19558568
[No Abstract] [Full Text] [Related]
15. Fix rooms could prevent infection in addicts.
Fronzo C
J Wound Care; 2017 Feb; 26(2):49. PubMed ID: 28182519
[No Abstract] [Full Text] [Related]
16. Mobile safe injecting facilities in Barcelona and Berlin.
Dietze P; Winter R; Pedrana A; Leicht A; Majó I Roca X; Brugal MT
Int J Drug Policy; 2012 Jul; 23(4):257-60. PubMed ID: 22464795
[No Abstract] [Full Text] [Related]
17. Australia. First, do harm reduction.
Science; 2014 Jul; 345(6193):156-8. PubMed ID: 25013058
[No Abstract] [Full Text] [Related]
18. ODYSSEAS: supervised use of drugs versus bureaucracy in Greece.
Malliori M; Galinaki S; Papakonstantinou AK
Lancet Psychiatry; 2015 Feb; 2(2):e3. PubMed ID: 26359756
[No Abstract] [Full Text] [Related]
19. The prospect of implementing a Safer Injection Facility in San Francisco: perspectives of community stakeholders.
Wenger LD; Arreola SG; Kral AH
Int J Drug Policy; 2011 May; 22(3):239-41. PubMed ID: 21334185
[TBL] [Abstract][Full Text] [Related]
20. Commentary on Pinkerton (2010): drug consumption rooms--time to accept their worth.
Lloyd C; Godfrey C
Addiction; 2010 Aug; 105(8):1437-8. PubMed ID: 20653623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
